COLLPLANT BIOTECHNOLOGIES LT (CLGN)

IL0004960188 - Common Stock

4  +0.08 (+2.06%)

After market: 4.21 +0.21 (+5.25%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

COLLPLANT BIOTECHNOLOGIES LT

NASDAQ:CLGN (12/6/2024, 8:00:00 PM)

After market: 4.21 +0.21 (+5.25%)

4

+0.08 (+2.06%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-22.03%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap45.80M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
Short Float %
Short Ratio
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CLGN Daily chart

Company Profile

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Company Info

COLLPLANT BIOTECHNOLOGIES LT

4 Oppenheimer Street, P.O. Box 4132

Rehovot 7670104

P: 972732325600

CEO: Yehiel Tal

Employees: 75

Website: https://www.collplant.com

CLGN News

News Image11 days ago - CollPlantCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

News Image26 days ago - CollPlantCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

News Image4 months ago - InvestorPlaceCLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024

CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

News Image4 months ago - BusinessInsiderCLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CollPlant Biotechnologies (NASDAQ:CLGN) just reported results for the second qu...

News Image4 months ago - CollPlantCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

News Image4 months ago - CollPlantCollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

/PRNewswire/ -- In a significant step in the advancement of regenerative medicine, CollPlant Biotechnologies (Nasdaq: CLGN) and Stratasys Ltd. (Nasdaq: SSYS)...

CLGN Twits

Here you can normally see the latest stock twits on CLGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example